跳至主要内容
临床试验/CTRI/2008/091/000061
CTRI/2008/091/000061招募中3 期

Randomized control trial (RCT) of Radiofrequency Ablation (RFA) and Percutaneous acetic acid (PAI) for the Treatment of Hepatocellular Carcinoma in Patients of Cirrhosis

Subrat Acharya0 个研究点目标入组 74 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Childâ??s A or B cirrhosis with liver mass.
  • Number of liver masses not more than 5 and the size of each <5cm in diameter.
  • No extrahepatic disease.
  • Absence of malignant portal vein thrombosis.
  • Platelet count more than 70,000/mm3
  • Prothrombin time more than 50%.
  • Written consent of patient.

排除标准

  • Childsâ??C cirrhosis with liver mass.
  • Liver mass >5cm in diameter.
  • Number of liver masses more than 5.
  • Peripherally located masses with no hepatic parenchyma around
  • Liver mass not discernable on ultrasound.
  • Extra hepatic disease like RP adenopathy, distant metastasis.
  • Coagulation disorders.
  • Unwilling patient

研究者

发起方
Subrat Acharya

相似试验